// App-Quantinova.ai

[SAT0130] : RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE IS THERE AN ASSOCIATION BETWEEN DISEASE MODIFYING ANTI RHEUMATIC DRUGS AND SURVIVAL?

Researchers

Presenter

  • M. Brown

Principal Investigators

  • C. Kelly

  • M. Nisar

  • G. Koduri

  • A. Young

  • E. Nikiphorou

  • S. Arthanari

  • F. Woodhead

  • A. PriceForbes

  • D. Middleton

  • O. Dempsey

  • J. Dawson

  • N. Sathi

  • Y. Ahmad

Medical Centers

  • Rheumatology, NHS, St Albans, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Rheumatoid arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • sulphasalazine

  • Penicillamine

  • Methotrexate

  • HWA-486

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim